Internal Medicine Articles & Analysis
47 news found
The manuscript entitled, "Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment," was published in the European Journal of Internal Medicine. The publication is available via Open Access at: https://www.ejinme.com/article/S0953-6205(24)00123-7/fulltext Cary Claiborne, CEO of Adial, commented, "Current pharmacological ...
Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted PRAC’s recommendation to add measures to minimise risk of serious side effects with JAK inhibitors for chronic inflammatory disorders. ...
She is board-certified medical doctor in Hematology/ Oncology as well as Internal Medicine, with more than 10 years of experience in patient care. ...
ByArdigen
Chirinjeev Kathuria MD, an investor, physician, and entrepreneur who is a graduate of Brown University’s Alpert School of Medicine, and Stanford University’s Graduate School of Business. ...
The results from the myCare-203A clinical study were featured in a poster presentation at the IASLC 2022 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer and held in Vienna, Austria from August 6-9, 2022. ...
Villines will be leading clinical strategy development and execution for Elucid’s commercial and in-development products. A distinguished professor of medicine, clinical cardiologist, and researcher focused on cardiovascular imaging and prevention, Dr. Villines is board-certified in internal medicine, cardiovascular diseases, cardiac ...
ByElucid
Since April 2013 he holds the position of Professor of Cardiology in the Cardiovascular Science Division of the National Heart and Lung Institute (NHLI) at the Faculty of Medicine, within the Imperial College of Science, Technology and Medicine, London. He is a Fellow of the American College of Cardiology and a Fellow of the European Society of Cardiology and ...
Rizo holds an M.D. from the University Ss Cyril and Methodius, Skopje, Macedonia, where she also completed a residency in internal medicine/hematology. She also has a Ph.D. in human leukemic stem cell biology from the University of Groningen, Groningen, Netherlands, and a Ph.D. in mouse stem cell biology from the University of Tokyo, Tokyo, Japan. ...
ByBayer AG
EsoCap AG organized a multidisciplinary scientific advisory board meeting with eight international experts in Barrett’s esophagus (BE) in Zurich EsoCap’s technology for the topical treatment of Barrett’s esophagus was recognized by the experts for having high potential for clinical success EsoCap’s proprietary and unique targeted application technology ...
Hayes, MD, FACP, FASCO, has joined the company’s Clinical Advisory Board (CAB). Dr. Hayes is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center. ...
Her experience also includes nine years with GlaxoSmithKline (GSK) in senior medical leadership roles including, Vice President of Medical Excellence and Quality, Vice President and Global Head, Infectious Diseases Medicines Development Center, as well as Vice President of Stiefel Laboratories, GSK's dermatology franchise focusing on acne treatments and anti-infectives. ...
He’s a professor of Circulatory Internal Medicine and an authority in the field of arrhythmia, who continued research and treatment of arrhythmia during his tenure. ...
Jee-Fu Huang, Professor, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, added, “Taiwan has one of the highest age-adjusted incident rates of HCC in East Asia, which is also the second leading cause of cancer-related deaths. ...
Borad, M.D., is currently a Professor of Medicine at Mayo Clinic College of Medicine and Science. He also serves as the Director of the GI Cancer Cellular, Gene and Virus Therapy lab, Director of the Liver and Biliary Cancer Research Program and Co-Director, Precision Cancer Therapeutics Program at the Center for Individualized Medicine at Mayo ...
ByCervoMed
The need for new therapies has never been greater,” said Professor Markus Lerch, President of the German Society for Internal Medicine. “A novel endoscopic approach that addresses a completely different pathophysiological mechanism of T2D could potentially change the landscape of our therapeutic ...
Feldman, PhD is an Associate Professor at the University of Maryland School of Medicine (UMSOM) Department of Microbiology and Immunology. Dr. Feldman received his PhD from the Department of Cell Biology at New York University School of Medicine, working with Drs. ...
Edsel is currently a KL2 Clinical Scholar at Scripps Translational Institute where he is completing his research track specialty in Allergy and Immunology and an internal medicine residency. His future work will focus on Siglec biology (e.g. ...
Vaishampayan, M.D., Professor, Internal Medicine, Division of Hematology/Oncology, University of Michigan Presentation Date: The poster, along with a pre-recorded presentation, will be available on the ASCO GI virtual meeting platform beginning Jan. 20, 2022. ...
ByAlkermes
“Liz is a proven R&D leader who brings a strong track record managing late-stage clinical development programs with particular expertise in cardiovascular medicine. Brian will leverage his extensive management and finance experience in both private and public biotech companies to accelerate Xylocor’s strategic and corporate objectives. ...
” Deep Lens’ software will pre-screen patients from Ventura County Hematology Oncology Specialists’ EMR (OncoEMR) and integrate molecular data feeds from Guardant Health, and Foundation Medicine as well as all pathology feeds to automatically identify qualified patients for clinical trials. ...